Papers
23
Total Citations
727
H-Index
15
About
Daniela E. Oprea-Lager is a leading researcher in oncological imaging, with a primary focus on prostate cancer (PCa). Her work centers on the clinical application and validation of prostate-specific membrane antigen (PSMA) PET/CT, particularly using the radiotracer [18F]DCFPyL, to improve staging, risk stratification, and treatment planning. A major contribution is her leadership of the SALT trial, which demonstrated the high accuracy of PSMA PET/CT for pelvic lymph-node staging in primary PCa. She has also pioneered the integration of quantitative PET metrics with machine learning for non-invasive risk stratification, as seen in her highly cited work on radiomics (135 citations). Oprea-Lager has been instrumental in developing and externally validating novel nomograms that incorporate PSMA PET and MRI to predict lymph-node metastases, outperforming traditional tools. Her research consistently shows that PSMA PET/CT improves oncological outcomes, particularly in guiding salvage radiation therapy for biochemical recurrence. With over 500 cumulative citations, her work is shaping clinical guidelines and advancing the role of molecular imaging in precision oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10